ECM
ZURA icon

ExodusPoint Capital Management’s Zura Bio ZURA Stock Holding History

ExodusPoint Capital Management’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-46,921
Closed -$246K – 2176
2025
Q4 		$246K Buy
+46,921
New +$186K ﹤0.01% 1355

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

ExodusPoint Capital Management's ZURA Position: Q1 2026 in Review

ExodusPoint Capital Management sold out of Zura Bio (ZURA) in Q1 2026, closing a stake of 46,921 shares — an estimated $246K sold.

ExodusPoint Capital Management first reported a position in ZURA in Q4 2025 and held it in 1 quarter. The position peaked at $246K in Q4 2025. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • ExodusPoint Capital Management reported no remaining Zura Bio position as of Q1 2026 after selling out during the quarter.
  • ExodusPoint Capital Management sold 46,921 Zura Bio shares in Q1 2026, an estimated $246K.
  • ExodusPoint Capital Management first reported a position in Zura Bio in Q4 2025 and held it in 1 quarter.
  • ExodusPoint Capital Management's Zura Bio position peaked at $246K in Q4 2025.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.